Skip to main content
RxSight, Inc. logo

RxSight, Inc. — Investor Relations & Filings

Ticker · RXST ISIN · US78349D1072 US Manufacturing
Filings indexed 414 across all filing types
Latest filing 2025-04-21 Proxy Solicitation & In…
Country US United States of America
Listing US RXST

About RxSight, Inc.

https://www.rxsight.com/

RxSight, Inc. is a commercial-stage medical technology company focused on ophthalmic solutions. The company develops, manufactures, and commercializes the Light Adjustable Lens (LAL) system, the first and only intraocular lens (IOL) technology that allows for vision customization after cataract surgery. The system comprises the photosensitive LAL and a companion Light Delivery Device (LDD). Post-implantation, the LDD applies targeted ultraviolet light to the lens, enabling surgeons to non-invasively adjust and refine a patient's vision to correct residual refractive errors, including low levels of astigmatism. This post-operative adjustability aims to provide a highly precise and optimized visual outcome for patients.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2025-04-21 English
ARS/A
Annual Report
2025-04-21 English
DEFA14A
Regulatory Filings
2025-04-21 English
4
Director's Dealing
2025-04-16 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-09 English
8-K
Regulatory Filings
2025-04-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.